F. Angriman, “What is the utility of Interleukin-6 blockade in patients with COVID-19?”, Rev Hosp Ital B.Aires, vol. 41, no. 4, pp. p. 193–195, Dec. 2021, doi: 10.51987/revhospitalbaires.v41i4.127.